DCF — MONMOUTH MEDICAL CENTER
Enterprise Value: $-760.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-760.3M
Enterprise Value
$-240.1M
PV of Cash Flows
$-520.2M
PV of Terminal Value
$-837.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $462.1M | $-47.6M | -10.0% | $-67.2M | $-61.1M |
| Year 2 | $476.0M | $-44.3M | -9.0% | $-64.4M | $-53.2M |
| Year 3 | $490.3M | $-40.7M | -8.0% | $-61.5M | $-46.2M |
| Year 4 | $505.0M | $-39.4M | -8.0% | $-60.8M | $-41.5M |
| Year 5 | $520.1M | $-39.3M | -8.0% | $-61.3M | $-38.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-760.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$448.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10802864792152404
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5